| UPDATED: 13:13, Wed, Mar 10, 2021
Link copied Sign up for FREE health tips to live a long and happy life
SUBSCRIBE Invalid email
When you subscribe we will use the information you provide to send you these newsletters. Sometimes they ll include recommendations for other related newsletters or services we offer. Our Privacy Notice explains more about how we use your data, and your rights. You can unsubscribe at any time.
Ovarian cancer is the fifth most common cancer diagnosed in women, specifically targeting the ovaries in the reproductive system. How would you know if there s a tumour growing inside of you? The Ovarian Cancer Action charity clarified that not all tumours in the ovaries are cancerous. Benign tumours (i.e. non-cancerous tumours) are rarely life-threatening and don t tend to spread to other parts of the body.
A LECTURER who lives in Evesham will be taking on a 400km six-day cycling challenge in Kenya later this year to raise money in memory of her sister who died from ovarian cancer. Sara Greedy s sister Nicola Williams had the disease twice in two and a half years before she passed away six years ago. Sara, who lives in Evesham with her husband Clive, is now hoping to raise money for the charities Breast Cancer Now, Jo s Cervical Cancer Trust, and Ovarian Cancer Action when she travels to Kenya in October with her friend to take on the challenge. As well as my sister Nikki, I’ve had a few friends and colleagues who have had cancer, and there are three charities that benefit from what we re going to do, said Sara.
Singula Bio provides new hope for cancer with diverse, individualised therapies pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Experts have hailed a quantum leap for women with ovarian cancer as a breakthrough treatment was given the go-ahead yesterday.
The drug niraparib was approved for use by regulators in the biggest improvement in 30 years for ovarian cancer treatment.
Niraparib can halt the disease for around 12 months, putting off the need for further chemotherapy and allowing women to have the best quality of life possible. It will be available for women with advanced ovarian cancer from their first round of treatment, meaning around 3,000 patients will have access to it every year.
Target Ovarian Cancer, a UK charity, described the treatment as a major milestone in the fight against the disease.